Clinical trial
Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation
NCT02093949 is registered in ClinicalTrials.gov with Hospital St. Joseph, Marseille, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation
- Lead sponsor
- Hospital St. Joseph, Marseille, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- August 31, 2016
- Enrollment
- 152 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.